Irish Continental Group plc (IR5B.IR)
EUR 5.24
(1.55%)
EUR 5.24
(1.55%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 128.6 Million | 126.3 Million | 56.8 Million | 46.1 Million | 84.8 Million | 61.5 Million |
| Net Income | 61.6 Million | 59.8 Million | -4.9 Million | -19 Million | 60.2 Million | 57.8 Million |
| Depreciation & Amortization | 64.2 Million | 60.5 Million | 52.5 Million | 39 Million | 36.8 Million | 22.1 Million |
| Deferred income taxes | -6.8 Million | - | -6.7 Million | 7.7 Million | -19.5 Million | -17.8 Million |
| Stock-based compensation | 2.8 Million | 3 Million | 1.3 Million | 200 Thousand | 1.9 Million | 2.4 Million |
| Change in working capital | 1.7 Million | 1.2 Million | 11.7 Million | 10.6 Million | 2 Million | -3.8 Million |
| Other non-cash items | 5.1 Million | 1.8 Million | 3.9 Million | 7.6 Million | 3.4 Million | 800 Thousand |
| Investing Cash Flow | -40.2 Million | -72.7 Million | -52.7 Million | 7.8 Million | -52.3 Million | -158.8 Million |
| Investments in PPE | -52.7 Million | -75.7 Million | -55.5 Million | -30.1 Million | -54.1 Million | -176.2 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 12.5 Million | 3 Million | 2.8 Million | 37.9 Million | 1.8 Million | 17.4 Million |
| Financing Cash Flow | -80.9 Million | -52.8 Million | -116.4 Million | -14.4 Million | -46.5 Million | 131.4 Million |
| Debt repayment | -40 Million | -7.6 Million | -87.5 Million | -3.7 Million | -9 Million | -154.3 Million |
| Dividends payments | -24.4 Million | -24.2 Million | - | - | -24.7 Million | -23.5 Million |
| Common Stock Repurchased | -21.4 Million | -49.2 Million | -19.8 Million | -1.7 Million | -12.9 Million | - |
| Common Stock Issuance | -2.7 Million | -2.8 Million | 700 Thousand | 200 Thousand | 100 Thousand | 600 Thousand |
| Other Financing Activities | 7.6 Million | 31 Million | -9.8 Million | -9.2 Million | -21.8 Million | 154.3 Million |
| Accounts receivables | 2 Million | -17 Million | 2.5 Million | 1.6 Million | -4.7 Million | -4.6 Million |
| Accounts payables | -2 Million | 17 Million | -2.5 Million | -1.6 Million | 4.7 Million | - |
| Inventory | 1.2 Million | -1.4 Million | -1.9 Million | 1.2 Million | 200 Thousand | -600 Thousand |
| Other working capital | 500 Thousand | 2.6 Million | 13.6 Million | 9.4 Million | 1.8 Million | -3.2 Million |
| Cash at beginning of period | 39 Million | 38.5 Million | 150.4 Million | 110.9 Million | 124.7 Million | 90.3 Million |
| Cash at end of period | 46.8 Million | 39 Million | 38.5 Million | 150.4 Million | 110.9 Million | 124.7 Million |
| Capital Expenditure | -52.7 Million | -75.7 Million | -55.5 Million | -30.1 Million | -54.1 Million | -176.2 Million |
| Effect of forex changes on cash | 300 Thousand | -300 Thousand | 400 Thousand | - | 200 Thousand | 300 Thousand |
| Net cash flow / Change in cash | 7.8 Million | 500 Thousand | -111.9 Million | 39.5 Million | -13.8 Million | 34.4 Million |
| Free Cash Flow | 75.9 Million | 50.6 Million | 1.3 Million | 16 Million | 30.7 Million | -114.7 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 6.85 Million | 6.85 Million | 61.6 Million | 24.35 Million | 24.35 Million | 6.45 Million |
| Depreciation & Amortization | 16.15 Million | 16.15 Million | 64.2 Million | 15.7 Million | 15.6 Million | 16.3 Million |
| Deferred income taxes | - | - | -6.8 Million | - | - | 1.65 Million |
| Stock-based compensation | 900 Thousand | 900 Thousand | 2.8 Million | 600 Thousand | 600 Thousand | 800 Thousand |
| Change in working capital | -10.45 Million | -10.45 Million | 1.7 Million | 4.05 Million | 4.05 Million | -2.45 Million |
| Other non-cash items | 17.5 Million | 17.5 Million | 5.1 Million | -15.3 Million | -15.2 Million | 13.8 Million |
| Investing Cash Flow | -9.45 Million | -9.45 Million | -40.2 Million | -5.45 Million | -5.45 Million | -14.65 Million |
| Investments in PPE | -8.85 Million | -8.85 Million | -52.7 Million | -6.3 Million | -6.3 Million | -14.65 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -600 Thousand | -600 Thousand | 12.5 Million | 850 Thousand | 850 Thousand | - |
| Financing Cash Flow | -19.3 Million | -19.3 Million | -80.9 Million | -17.95 Million | -17.95 Million | -22.5 Million |
| Debt repayment | - | - | -40 Million | - | - | - |
| Dividends payments | -8.15 Million | -8.15 Million | -24.4 Million | -3.8 Million | -3.8 Million | -8.4 Million |
| Common Stock Repurchased | -6.35 Million | -6.35 Million | -21.4 Million | -10.7 Million | -10.7 Million | -1.55 Million |
| Common Stock Issuance | - | - | -2.7 Million | - | - | - |
| Other Financing Activities | -4.8 Million | -4.8 Million | 7.6 Million | -3.45 Million | -3.45 Million | -12.55 Million |
| Accounts receivables | -8.45 Million | -8.45 Million | 2 Million | 3.9 Million | 3.9 Million | -2.9 Million |
| Accounts payables | - | - | -2 Million | - | - | - |
| Inventory | -2 Million | -2 Million | 1.2 Million | 150 Thousand | 150 Thousand | 450 Thousand |
| Other working capital | - | - | 500 Thousand | - | - | - |
| Cash at beginning of period | - | - | 39 Million | - | - | - |
| Cash at end of period | 2.2 Million | 2.2 Million | 46.8 Million | 5.9 Million | 5.9 Million | -2 Million |
| Capital Expenditure | -8.85 Million | -8.85 Million | -52.7 Million | -6.3 Million | -6.3 Million | -14.65 Million |
| Effect of forex changes on cash | - | - | 300 Thousand | -100 Thousand | -100 Thousand | 250 Thousand |
| Net cash flow / Change in cash | 2.2 Million | 2.2 Million | 7.8 Million | 5.9 Million | 5.9 Million | -2 Million |
| Free Cash Flow | 22.1 Million | 22.1 Million | 75.9 Million | 23.1 Million | 23.1 Million | 20.25 Million |
OBRN
BGBIO
TD-PFA
HNSA
CFF
688659